The estimated Net Worth of Richard J. Gregory is at least $879 ezer dollars as of 18 November 2019. Richard Gregory owns over 10,806 units of Homology Medicines Inc stock worth over $10,050 and over the last 9 years he sold FIXX stock worth over $641,997. In addition, he makes $226,913 as Independent Director at Homology Medicines Inc.
Richard has made over 8 trades of the Homology Medicines Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 10,806 units of FIXX stock worth $324 on 18 November 2019.
The largest trade he's ever made was selling 36,643 units of Homology Medicines Inc stock on 22 February 2019 worth over $205,201. On average, Richard trades about 6,497 units every 74 days since 2015. As of 18 November 2019 he still owns at least 10,806 units of Homology Medicines Inc stock.
You can see the complete history of Richard Gregory stock trades at the bottom of the page.
Dr. Richard J. Gregory Ph.D. serves as Independent Director of the Company. Prior to his retirement, Dr. Gregory served as Executive Vice President and Chief Scientific Officer of ImmunoGen, Inc., a biotechnology company, from 2015 until August 2019. Prior to joining ImmunoGen, Inc., he spent 25 years at Genzyme Corporation, a biotechnology company, in roles of increasing responsibility, including Senior Vice President and Head of Research from 2003 until Genzyme Corporation’s acquisition by Sanofi in 2011, and Head of Research and Development for Genzyme from 2011 through 2014. Dr. Gregory serves as a director of ProMIS Neurosciences, Inc. Dr. Gregory received his B.A. in Science from Virginia Tech and holds a Ph.D. from the University of Massachusetts, Amherst, and completed his post-doctoral work at the Worcester Foundation for Experimental Biology.
As the Independent Director of Homology Medicines Inc, the total compensation of Richard Gregory at Homology Medicines Inc is $226,913. There are 10 executives at Homology Medicines Inc getting paid more, with Arthur Tzianabos having the highest compensation of $5,062,880.
Richard's mailing address filed with the SEC is C/O HOMOLOGY MEDICINES, INC., ONE PATRIOTS PARK, BEDFORD, MA, 01730.
Over the last 7 years, insiders at Homology Medicines Inc have traded over $108,214,465 worth of Homology Medicines Inc stock and bought 3,033,333 units worth $51,999,993 . The most active insiders traders include Steven Gillis, James Edeerfield Management... és Kush Parmar. On average, Homology Medicines Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,785. The most recent stock trade was executed by Paul Alloway on 25 March 2024, trading 23,530 units of FIXX stock currently worth $21,883.
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Homology Medicines Inc executives and other stock owners filed with the SEC include: